MedMira Introduces Expanded Multiplo(TM) Product Line at US Military Conference

About this update from Medmira Inc.

[{"type":"text","content":"\n\n\n\nHALIFAX, Aug. 10 /CNW/ - MedMira Inc., ("MedMira") (TSX Venture: MIR,\nNASDAQ: MMIRF), a developer and marketer of rapid diagnostic technology and\nsolutions, announced today the introduction of new Multiplo(TM) rapid tests at\nthe US Military's Advanced Technology Applications for Casualty Combat Care\n(ATACCC) Conference taking place this week in St. Pete's Beach, FL.\n\n\nMedMira is launching several new combination rapid tests for infectious\nand tropical diseases, and sexually transmitted diseases at the ATACCC\nConference. Specifically these new tests will be used to diagnose disease such\nas HIV, Hepatitis B and C, syphilis, malaria, and Dengue fever in various\ncombinations. The expanded Multiplo(TM) line also includes monitoring\ncapabilities for vaccination effectiveness, applicable in military\npre-deployment screening, public health vaccination programs, and vaccine\ndevelopment trials.\n\n\nEmploying MedMira's distinctive and patented rapid flow-through\ntechnology, many of these new Multiplo(TM) tests will be the first of their\nkind in the diagnostics industry. The technology's unique advantages are\nmultiple instant results on one test cartridge as well as the ease with which\nnew test combinations can be geared up for full commercialization.\n\n\n"Introducing our latest Multiplo(TM) diagnostic combinations at the\nATACCC Conference is a good opportunity to clearly demonstrate the unique\nadvantages and diversity of applications that our rapid diagnostic technology\ncan offer to military medicine as well as civilian healthcare," said Hermes\nChan, CEO, MedMira Inc. "There are some exceptional challenges in military\nmedicine and we believe that our rapid diagnostics and technology can be very\nbeneficial, bringing increased efficiency and improving patient outcomes."\n\n\nThe ATACCC brings together over 1,200 scientists and medical personnel\nand is the Department of Defense's (DOD) premier scientific meeting that\nfocuses on the battlefield medical needs of warfighters and on recent advances\nin trauma surgery and medicine.\n\n\nAbout MedMira\n\n\nMedMira is a leading developer and manufacturer of flow-through rapid\ndiagnostics. The company's tests provide hospitals, labs, clinics and\nindividuals with reliable, rapid diagnosis for diseases such as HIV and\nhepatitis C in j...

More updates from Medmira Inc.